Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Oral Adherence in Adults with Acute Myeloid Leukemia: Results of a Mixed Methods Study

Ashley Leak Bryant, PhD RN, Thomas W. LeBlanc, MDMA,MHS, Tara Albrecht, PhDANP, Ya-Ning Chan, Jaime Richardson, Matthew C Foster, MD, Dang Malisa, Susie Owenby, Debra Wujcik, PhD

Blood (2019) 134 (Supplement_1): 2215.

https://doi.org/10.1182/blood-2019-130514

Published: 2019

Journal Articles

Medicare Patients Receiving Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma: A First Real-World Look at Patient Characteristics, Healthcare Utilization and Costs

Karl M. Kilgore, PhD, Iman Mohammadi, PhD, Amy Schroeder, BPharm, Christie Teigland, PhD, Anna Purdum, PharmD,MS, Gunjan L. Shah, MD

Blood (2019) 134 (Supplement_1): 793.

https://doi.org/10.1182/blood-2019-124364

Published: 2019

Journal Articles

Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma

Gregory Sampang Calip, PharmD, MPH, PhD, Jifang Zhou, MD, Karen Sweiss, PharmD, Pritesh Patel, MD, Alemseged Ayele Asfaw, MSc, B Pharm, Todd Lee, PharmD, PhD, Brian C.-H. Chiu, PhD, Edith A. Nutescu, PharmD., MS, FCCP

Blood (2018) 132 (Supplement 1): 4693.

https://doi.org/10.1182/blood-2018-99-116867

Published: 2018

Journal Articles

Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA)

Andrea Sitlinger, MD, Rishi Sachdev, David Anderson, BS/MS, S. Yousuf Zafar, MD MHS

Blood (2017) 130 (Supplement 1): 4680.

https://doi.org/10.1182/blood.V130.Suppl_1.4680.4680

Published: 2017

Journal Articles

Treatment of Primary Cutaneous Marginal Zone B-Cell Lymphomas with Intralesional Rituximab

Eva Domingo Domenech, MD, Queralt Salas, MD, Octavio Servitje, MD PhD, Fina Climent, MD PhD, Helena Pomares, Ana Lucas, MD, Carmen Aguilera, Mrs, Alessandra Comai, Santiago Mercadal, MD, Eva Gonzalez Barca, PhD, Anna Sureda, MD PhD

Blood (2016) 128 (22): 1796.

https://doi.org/10.1182/blood.V128.22.1796.1796

Published: 2016

Journal Articles

Primary Cutaneous Marginal Zone B-Cell Lymphoma Treated with Intralesional Rituximab: Experience of a Single Center

Eva Domingo-Domenech, MD, Queralt Salas, MD, Fina Climent, MD PhD, Carmen Aguilera, Mrs, Helena Pomares, MD, Eva González-Barca, MD PhD, Santiago Mercadal, MD, Anna Lucas, MD, Alberto Fernandez de Sevilla, MD PhD, Anna Sureda, MD PhD, Octavio Servitje, MD PhD

Blood (2015) 126 (23): 5087.

https://doi.org/10.1182/blood.V126.23.5087.5087

Published: 2015

Journal Articles

Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

Nicola Stefano Fracchiolla, MD, Elisabetta Todisco, MD PhD, Andrea Bilancia, Sara Gandolfi, MD, Valentina Mancini, MD, Laura Marbello, MD, Massimo Bernardi, MD, Andrea Assanelli, MD, Nicola Orofino, MD, Ramona Cassin, MD, Mariarita Sciumè, MD, Francesca Guidotti, MD, Roberto Cairoli, MD, Fabio Ciceri, MD, Armando Santoro, MD, Agostino Cortelezzi, MD, Giuseppe Rossi, MD

Blood (2015) 126 (23): 5611.

https://doi.org/10.1182/blood.V126.23.5611.5611

Published: 2015

Journal Articles

High Efficiency and Tolerance of Temozolomide in Relapse/Refractory Primary Intra-Ocular Lymphoma (R/R PIOL). a Retrospective Multicentric Study from the LOC Network

Marine Baron, Emmanuel Gyan, MD PhD, Hélène Merle-Beral, MD PhD, Veronique Leblond, MD PhD, Nathalie Cassoux, Valerie Touitou, Bahram Bodaghi, Adil Darugar, Sylvain Choquet, MD

Blood (2014) 124 (21): 3080.

https://doi.org/10.1182/blood.V124.21.3080.3080

Published: 2014

Journal Articles

Non-Inferior Pharmacokinetics with Comparable Safety and Response Rates for Subcutaneous (SC), Compared with Intravenous (IV), Rituximab in Combination with Fludarabine and Cyclophosphamide (FC) in Patients (Pts) with Untreated Chronic Lymphocytic Leukemia (CLL): Part 2 of the Phase Ib SAWYER Study (BO25341)

Sarit Assouline, MD MSc, Valeria Buccheri, MD PhD, Alain Delmer, MD, Gianluca Gaidano, MD PhD, Michael Brewster, BSc, Olivier Catalani, Sai Li, MD PhD, Christine McIntyre, PhD, Pakeeza Sayyed, PhD, Xavier C Badoux, MBBS

Blood (2014) 124 (21): 1995.

https://doi.org/10.1182/blood.V124.21.1995.1995

Published: 2014

Journal Articles

The EORTC Cutaneous T-Cell Lymphoma (CTCL) Platform

Sean Whittaker, Robert Knobler, Pablo Luis Ortiz-Romero, Maarten Vermeer, Matthias Karrasch, Baktiar Hasan, Stefan Suciu, PhD, Denis Lacombe, Martine Bagot

Blood (2010) 116 (21): 4896.

https://doi.org/10.1182/blood.V116.21.4896.4896

Published: 2010

Journal Articles

Hodgkin Variant of Richter's Syndrome: Report of 34 Cases. A Role of EBV in Transformation.

Bénédicte Deau, MD, Caroline Bonmati, MD, Emmanuel Bachy, MD, Xavier Carles, MD, Pauline Brice, MD, Franck Morschhauser, MD, Philippe Rousselot, MD, PhD, Marie-Olivia Chandesris, MD, Richard Delarue, MD, Bruno Varet, MD, Vincent Ribrag, MD, Olivier Hermine, MD, PhD

Blood (2009) 114 (22): 1550.

https://doi.org/10.1182/blood.V114.22.1550.1550

Published: 2009

Journal Articles

Bloodless Cancer Treatment Results of Patients Who Do Not Want Blood Transfusion: Single Center Experience of 77 Cases

Sung Hyun Kim, MD, PhD, Sung Yong Oh, Hyuk-Chan Kwon, Suee Lee, Dong Mee Lee, Kyeong Hee Kim, Jin-Yeong Han, Joo- In Park, Jong-Hwan Lee, Kyu-Yeol Lee, Hyo-Jin Kim

Blood (2008) 112 (11): 4068.

https://doi.org/10.1182/blood.V112.11.4068.4068

Published: 2008

Journal Articles

An Assessment of the Impact That Chemotherapy Treatment Has on Employment Status in Individuals with Lymphoma.

Jeff Horn, RN, DipHEN, BN, Ann T. Shaw, RN DipHEN BSc (Hons)

Blood (2006) 108 (11): 5492.

https://doi.org/10.1182/blood.V108.11.5492.5492

Published: 2006

Journal Articles

The Effect of Chemotherapy Shortage in Iraq during the United Nations (UN) Sanctions on Outcome of Children with Acute Lymphocytic Leukemia (ALL).

Haydar Frangoul, Mazin F. Al-Jadiry, Yu Shyr, Bashar Shakhtour, Salma A. Al-Hadad

Blood (2006) 108 (11): 3317.

https://doi.org/10.1182/blood.V108.11.3317.3317

Published: 2006

Journal Articles

Dose-Modified Oral Chemotherapy for AIDS-Related Non-Hodgkin’s Lymphoma (AR-NHL) in East Africa.

Jackson Orem, MD, O.W. Mwanda, MD, P. Fu, C. Banura, J. Kakembo, A. Ness, J. Johnson, V. Subbiah, MD, J. Bako, J. Black, E. Katongole-Mbidde, S.C. Remick, MD

Blood (2006) 108 (11): 488.

https://doi.org/10.1182/blood.V108.11.488.488

Published: 2006

Journal Articles

SNP Genotypes as Prognostic Factors Associated with Staging in Myeloma: The First Combined SNP Association Analysis of SWOG, ECOG, and MRC Clinical Trials from the Bank on a Cure.

Brian Van Ness, John Crowley, Emily Blood, Erik Rasmussen, Christine Ramos, Suzanne Grindle, Gareth Morgan, David Johnson, Antje Hoering, Philip Greipp, Bart Barlogie, Brian Durie

Blood (2005) 106 (11): 3489.

https://doi.org/10.1182/blood.V106.11.3489.3489

Published: 2005

Journal Articles

Effective Treatment of Elderly Acute Myeloid Leukaemia (AML) with Continuous Combined Granulocyte Colony Stimulating Factor (G-CSF) and Single Oral Chemotherapeutic Agents.

Jennifer L. Curnow, MBBS, Francesco Piccolo, MBBS, Christopher M. Ward, PhD, MBBS, BMedSci, Luke Coyle, MBBS, Keith Fay, MBBS, Naomi Mackinlay, MBBS, Sundra Ramanathan, MBBS, Christopher Arthur, MBBS

Blood (2004) 104 (11): 4515.

https://doi.org/10.1182/blood.V104.11.4515.4515

Published: 2004

NARROW

Oral Adherence in Adults with Acute Myeloid Leukemia: Results of a Mixed Methods Study

Medicare Patients Receiving Chimeric Antigen Receptor T-Cell Therapy for Non-Hodgkin Lymphoma: A First Real-World Look at Patient Characteristics, Healthcare Utilization and Costs

Venous Thromboembolic Prophylaxis Following Treatment Initiation for Multiple Myeloma

Insurance Design and Out-of-Pocket (OOP) Costs: a Comparison of Oral and Intravenous (IV) Treatment Plans for Chronic Lymphocytic Leukemia (CLL) in the Era of the Affordable Care Act (ACA)

Treatment of Primary Cutaneous Marginal Zone B-Cell Lymphomas with Intralesional Rituximab

Primary Cutaneous Marginal Zone B-Cell Lymphoma Treated with Intralesional Rituximab: Experience of a Single Center

Peripherally Inserted Central Catheters (PICCs) Implantation in the Clinical Management of Oncohematologic Patients: Results of a Large Multicenter, Retrospective Study of the REL Group (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)

High Efficiency and Tolerance of Temozolomide in Relapse/Refractory Primary Intra-Ocular Lymphoma (R/R PIOL). a Retrospective Multicentric Study from the LOC Network

The EORTC Cutaneous T-Cell Lymphoma (CTCL) Platform

Hodgkin Variant of Richter's Syndrome: Report of 34 Cases. A Role of EBV in Transformation.

Bloodless Cancer Treatment Results of Patients Who Do Not Want Blood Transfusion: Single Center Experience of 77 Cases

An Assessment of the Impact That Chemotherapy Treatment Has on Employment Status in Individuals with Lymphoma.

The Effect of Chemotherapy Shortage in Iraq during the United Nations (UN) Sanctions on Outcome of Children with Acute Lymphocytic Leukemia (ALL).

Dose-Modified Oral Chemotherapy for AIDS-Related Non-Hodgkin’s Lymphoma (AR-NHL) in East Africa.

SNP Genotypes as Prognostic Factors Associated with Staging in Myeloma: The First Combined SNP Association Analysis of SWOG, ECOG, and MRC Clinical Trials from the Bank on a Cure.

Effective Treatment of Elderly Acute Myeloid Leukaemia (AML) with Continuous Combined Granulocyte Colony Stimulating Factor (G-CSF) and Single Oral Chemotherapeutic Agents.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only